RE:RE:RE:RE:RE:RE:RE:WowMary, your point has long been a frustration with shareholders. DM has such a great product line - AI's my fav - but there is no professional marketing. Your example is dead on. Another example, NexaSMART should have never been released without a professional marketing campaign to get everyone hyped up about it. I'm starting to wonder if their idea of a marketing campaign is releasing a PR. Marshall mentioned in one of the webinars last summer, that they had hired a marketing firm, but evidence of that is still a mystery. Still, if you read about security and health tech, AI is the place to be. GLTA ~ Erica
maryhill wrote: When you read a CBDT press release on their Covid test platform it makes you say WOW- BUY
When you read a Datametrex release on their Covid test ambitions its like, yeah were testing . For cryin out loud Marshall, 12000 tests are record numbers for you, put that news out there , get the markets excited. Your spit tests are what clients asked for and thats why you got them. The demand you see for saliva products will open up so many markets for us.
Wake up Marshal... Get the word out, hire a press reporter if you cant do it
GalAnonymous wrote: I agree, it basically felt like rewatching Marshall's last interview with Agoracom. I was expecting news but he basically repeated what I already heard/knew. 12000 tests a week and more AI contracts was great to hear though... well the bottom line is still the same - it's a great company with lots of things in the pipeline and great revenue so the numbers will be reflected in SP sooner or later. Marshall could learn from CBDT CEO a bit though. He learnt really fast that sometimes less is more: it's better to defer from interviews and PR if you don't have much to add or if the news is not substantial. And look at CBDT today. Anyways, I'm holding because there is definitely tons of potential here, if anything I'll add at the pullback from the interview but I must say I'm disappointed too.